Capital World Investors
ICPT

Capital World Investors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Capital World Investors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-213,137
Closed -$10.2M – 570
2020
Q2 		$10.2M Hold
213,137
– – ﹤0.01% 472
2020
Q1 		$13.4M Hold
213,137
– – ﹤0.01% 429
2019
Q4 		$26.4M Hold
213,137
– – 0.01% 403
2019
Q3 		$14.1M Hold
213,137
– – ﹤0.01% 444
2019
Q2 		$17M Hold
213,137
– – ﹤0.01% 458
2019
Q1 		$23.8M Hold
213,137
– – 0.01% 420
2018
Q4 		$21.5M Hold
213,137
– – 0.01% 429
2018
Q3 		$26.9M Hold
213,137
– – 0.01% 441
2018
Q2 		$17.9M Sell
213,137
-1,031,622
-83% -$75.5M ﹤0.01% 470
2018
Q1 		$76.6M Buy
1,244,759
+81,000
+7% +$4.88M 0.02% 325
2017
Q4 		$68M Sell
1,163,759
-690,200
-37% -$43.5M 0.01% 323
2017
Q3 		$108M Sell
1,853,959
-71,500
-4% -$7.7M 0.02% 285
2017
Q2 		$233M Sell
1,925,459
-59,500
-3% -$6.89M 0.05% 216
2017
Q1 		$224M Sell
1,984,959
-157,500
-7% -$18.4M 0.05% 220
2016
Q4 		$233M Buy
2,142,459
+75,500
+4% +$8.99M 0.06% 220
2016
Q3 		$340M Buy
2,066,959
+13,000
+0.6% +$2.05M 0.09% 182
2016
Q2 		$293M Buy
2,053,959
+160,000
+8% +$23.3M 0.08% 195
2016
Q1 		$243M Buy
1,893,959
+326,422
+21% +$38.5M 0.07% 210
2015
Q4 		$234M Buy
1,567,537
+156,600
+11% +$26.5M 0.07% 218
2015
Q3 		$234M Buy
1,410,937
+630,937
+81% +$139M 0.07% 221
2015
Q2 		$188M Hold
780,000
– – 0.05% 257
2015
Q1 		$220M Buy
780,000
+277,142
+55% +$60M 0.06% 235
2014
Q4 		$78.4M Sell
502,858
-233,942
-32% -$43.2M 0.02% 323
2014
Q3 		$174M Hold
736,800
– – 0.05% 258
2014
Q2 		$174M Sell
736,800
-267,951
-27% -$70.6M 0.05% 254
2014
Q1 		$331M Buy
+1,004,751
New +$339M 0.09% 193
2013
Q4 		– Sell
-270,000
Closed -$18.6M – 498
2013
Q3 		$18.6M Sell
270,000
-130,000
-33% -$6.42M 0.01% 411
2013
Q2 		$17.9M Buy
+400,000
New +$13.7M 0.01% 403

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Capital World Investors's ICPT Position: Q3 2020 in Review

Capital World Investors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 213,137 shares — an estimated $10.2M sold.

Capital World Investors first reported a position in ICPT in Q2 2013 and held it in 28 quarters. The position peaked at $340M in Q3 2016. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

  • Capital World Investors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Capital World Investors sold 213,137 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10.2M.
  • Capital World Investors first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
  • Capital World Investors's Intercept Pharmaceuticals, Inc. position peaked at $340M in Q3 2016.
  • 177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Capital World Investors's 13F filing for Q3 2020, filed 13 Nov 2020.